FDA-approved GLP-1/GIP medications for weight loss and type 2 diabetes, including Ozempic, Wegovy, Zepbound, and Mounjaro, may also be eligible for coverage
30 GLP-1RAs and Obesity According to WHO data, 43% of adults over 18 were overweight and about 16% worldwide were obese in 2022
In addition, a reduction in the dose of sulfonylureas is usually recommended when a gliptin is added, since its pharmacodynamic interaction with the sulfonylurea may result in a higher risk of hypoglycemia
Regardless of which option you lean toward, a prescription from a licensed medical doctor practicing within the USA is required
Steady Nourishment Supports Energy Small, nutrient-dense meals provide steady fuel when appetite is low